Welcome to our dedicated page for Nexscient SEC filings (Ticker: NXNT), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Struggling to trace how Nexscient recognizes AI subscription revenue or which IIOT acquisitions drove last quarter’s growth? The company’s disclosures span hundreds of pages, and key details—like capitalized software costs or insider stock sales before a platform launch—are buried deep in footnotes.
Stock Titan solves that problem. Our AI-powered summaries translate every Nexscient SEC filing into plain English, flagging the metrics investors ask for most. Need the latest Nexscient quarterly earnings report 10-Q filing or a Nexscient 8-K material events explained update? We post them in real time as soon as EDGAR releases. Curious about Nexscient insider trading Form 4 transactions? Get instant alerts with a timeline of Nexscient Form 4 insider transactions real-time, plus context on how those trades align with product announcements.
Each document type reveals different insights and our platform guides you to the right one:
- 10-K annual report – subscription backlog, segment margins, and R&D outlays, with a Nexscient annual report 10-K simplified overview.
- 10-Q – quarter-over-quarter trend tables, instantly compared by our AI for fast Nexscient earnings report filing analysis.
- Form 4 – track Nexscient executive stock transactions Form 4 and spot buying or selling patterns.
- DEF 14A proxy statement – see a Nexscient proxy statement executive compensation breakdown of AI talent incentives.
From understanding Nexscient SEC documents with AI to monitoring material contracts, Stock Titan delivers the comprehensive, up-to-the-second coverage professionals need—no scrolling, no guesswork.
Nexscient, Inc. (NXNT) filed its quarterly report for the three months ended September 30, 2025. The company reported no revenue and a net loss of $166,981. Cash was $58,953 at quarter end, against total liabilities of $667,048 and a stockholders’ deficit of $431,611. Operating expenses rose to $154,934, driven by higher general and administrative costs, partly offset by lower research and development. Convertible debentures outstanding totaled $530,000, with a 9% rate and a floor conversion price of $0.50 per share.
The company disclosed substantial doubt about its ability to continue as a going concern and cited an estimated cash burn of about $22,500 per month. Management concluded disclosure controls and internal control over financial reporting were not effective due to material weaknesses. Subsequent to quarter end, the CFO resigned and the CEO assumed interim CFO duties, and Nexscient entered a 12‑month strategic alliance with Tekcapital, issuing 300,000 restricted shares as consideration. Common shares outstanding were 21,323,312 as of September 30, 2025, and 21,623,312 as of November 12, 2025.
Nexscient, Inc. (OTCQB: NXNT) announced a strategic alliance with Tekcapital plc to source university-originated technologies aligned with Nexscient’s AI and advanced computing focus areas. The agreement is effective November 7, 2025 and runs for 12 months, during which Tekcapital will present opportunities for Nexscient’s review and potential acquisition. Once candidates are approved by Nexscient, Tekcapital will lead early-stage negotiations and structure transactions for Nexscient to acquire.
As consideration for services over the term, Nexscient will issue 300,000 shares of its restricted common stock to Tekcapital. The arrangement is intended to expand Nexscient’s access to a curated pipeline of innovations while formalizing Tekcapital’s role in sourcing and initial deal structuring.
Nexscient, Inc. (NXNT) announced a leadership change. On November 5, 2025, Chief Financial Officer Michael Portera resigned, effective immediately. The company stated the resignation was not the result of any disagreement with its operations, policies, or practices.
Chief Executive Officer Fred E. Tannous was appointed Interim Chief Financial Officer on the same date and will hold both roles while the company searches for a permanent CFO. Nexscient has begun identifying and evaluating candidates for the position.
Nexscient, Inc. discloses selected 2025 annual-report items showing capital raising, tax and equity activity and operational observations. The company reported outstanding convertible debentures of $480,000 that mature in two years and convert into common stock at the lower of $0.75 per share or 20% below a ten-day VWAP with a $0.50 minimum, and are holder-convertible subject to lock-up and leak-out provisions. The filing references an authorized capital structure of 85,000,000 shares (75,000,000 common; 10,000,000 preferred). During the year the company issued 250,000 common shares to the CEO related to a promissory-note arrangement and repaid a zero-interest loan. Deferred tax assets of $1,065,000 exist but carry a full valuation allowance, reducing the effective tax rate to 0%. Valuation allowances increased by $129,000 in 2025. The filing notes challenges in data preparation for AI projects and references Level 1 and Level 3 fair-value inputs.
FAQ
What is the current stock price of Nexscient (NXNT)?
